{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T03:13:14Z","timestamp":1771902794333,"version":"3.50.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12893-019-0508-6","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T12:02:49Z","timestamp":1556193769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pseudomyxoma peritonei induced by low-grade appendiceal mucinous neoplasm accompanied by rectal cancer: a case report and literature review"],"prefix":"10.1186","volume":"19","author":[{"given":"Shili","family":"Ning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanliang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuwen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,25]]},"reference":[{"key":"508_CR1","first-page":"233","volume":"30","author":"PH Sugarbaker","year":"1996","unstructured":"Sugarbaker PH, Ronnett BM, Archer A, et al. Pseudomyxoma peritonei syndrome. Adv Surg. 1996;30:233\u201380.","journal-title":"Adv Surg"},{"issue":"6","key":"508_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/01.pap.0000194625.05137.51","volume":"12","author":"RK Pai","year":"2005","unstructured":"Pai RK, Longacre TA. Appendiceal mucinous tumors and Pseudomyxoma Peritonei: histologic features, diagnostic problems, and proposed classification. Adv Adv Anat Pathol. 2005;12(6):291\u2013311.","journal-title":"Adv Adv Anat Pathol"},{"key":"508_CR3","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1200\/JCO.2012.42.3764","volume":"30","author":"EK Nakakura","year":"2012","unstructured":"Nakakura EK. Pseudomyxoma peritonei: more questions than answers. J Clin Oncol. 2012;30:2429\u201330.","journal-title":"J Clin Oncol"},{"issue":"8","key":"508_CR4","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1067\/j.cpsurg.2008.04.003","volume":"45","author":"RM Smeenk","year":"2008","unstructured":"Smeenk RM, Bruin SC, van Velthuysen ML, Verwaal VJ. Pseudomyxoma peritonei. Curr Probl Surg. 2008;45(8):527\u201375.","journal-title":"Curr Probl Surg"},{"issue":"1","key":"508_CR5","first-page":"55","volume":"50","author":"F Khaldi","year":"1993","unstructured":"Khaldi F, Ben Chehida F, Mrabet S, et al. Iconographic rubric Pseudomyxoma peritonei complicating cancer of the rectum. Arch Fr Pediatr. 1993;50(1):55\u20136.","journal-title":"Arch Fr Pediatr"},{"issue":"5","key":"508_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1590\/S0102-86502007000500014","volume":"22","author":"R Saad-Hossne","year":"2007","unstructured":"Saad-Hossne R, Prado RG, Bakonyi Neto A, Marchezan MA. Peritoneal pseudomyxoma associated with synchronic malignant mucinous neoplasias of the cecum, appendix and rectum. Case report and review of the literature. Acta Cir Bras. 2007;22(5):407\u201311.","journal-title":"Acta Cir Bras"},{"issue":"1","key":"508_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10151-010-0654-4","volume":"15","author":"CM Newman","year":"2011","unstructured":"Newman CM, Moran BJ. Pseudomyxoma peritonei presenting as recurrent rectal cancer: a preventable condition? Tech Coloproctol. 2011;15(1):89\u201390.","journal-title":"Tech Coloproctol"},{"issue":"5","key":"508_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2017.05.019","volume":"354","author":"S Wang","year":"2017","unstructured":"Wang S, Yin WB, Kong LY. Anal Fistulas Due to Pseudomyxoma Anorectum. Am J Med Sci. 2017;354(5):e9.","journal-title":"Am J Med Sci"},{"key":"508_CR9","unstructured":"Sugarbaker (2007 Complete cytoreduction for pseudomyxoma peritonei (Sugarbaker technique). Guidance and guidelines NICE [Internet] \n                    https:\/\/www.nice.org.uk\/guidance\/ipg56\n                    \n                  . Accessed 24 Nov 2016."},{"issue":"2","key":"508_CR10","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ejso.2007.04.002","volume":"34","author":"RM Smeenk","year":"2008","unstructured":"Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol. 2008;34(2):196\u2013201.","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"508_CR11","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/00000658-191706000-00009","volume":"65","author":"PJ Reel","year":"1917","unstructured":"Reel PJ. Cystic dilatation of the vermiform appendix. Ann Surg. 1917;65(6):743\u20136.","journal-title":"Ann Surg"},{"issue":"12","key":"508_CR12","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1097\/DCR.0b013e3182a62b0d","volume":"56","author":"S Dayal","year":"2013","unstructured":"Dayal S, Taflampas P, Riss S, et al. Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved. Dis Colon Rectum. 2013;56(12):1366\u201372.","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"508_CR13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S1055-3207(03)00026-7","volume":"12","author":"A Mart\u00ednez","year":"2003","unstructured":"Mart\u00ednez A, Ferron Moran BJ, Cecil TD. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am. 2003;12(3):585\u2013603.","journal-title":"Surg Oncol Clin N Am"},{"issue":"10","key":"508_CR14","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.3748\/wjg.v13.i10.1622","volume":"13","author":"SE Lee","year":"2007","unstructured":"Lee SE, Jang JY, Yang SH, Kim SW. Intraductal papillary mucinous carcinoma with atypical manifestations: report of two cases. World J Gastroenterol. 2007;13(10):1622\u20135.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"508_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/jso.20427","volume":"93","author":"RM Smeenk","year":"2006","unstructured":"Smeenk RM, Bex A, Verwaal VJ, et al. Pseudomyxoma peritonei and the urinary tract: involvement and treatment related complications. J Surg Oncol. 2006;93(1):20\u20133.","journal-title":"J Surg Oncol"},{"issue":"1","key":"508_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3892\/etm.2013.1408","volume":"7","author":"H Wang","year":"2014","unstructured":"Wang H, Wang X, Ju Y, et al. Clinicopathological features and prognosis of pseudomyxoma peritonei. Exp Ther Med. 2014;7(1):185\u201390.","journal-title":"Exp Ther Med"},{"issue":"1","key":"508_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.suronc.2009.12.004","volume":"21","author":"A Mart\u00ednez","year":"2012","unstructured":"Mart\u00ednez A, Ferron G, Mery E, et al. Peritoneal pseudomyxoma arising from the urachus. Surg Oncol. 2012;21(1):1\u20135.","journal-title":"Surg Oncol"},{"key":"508_CR18","doi-asserted-by":"crossref","unstructured":"Bevan KE, Mohamed F, Moran B. Pseudomyxoma peritonei. World J Gastrointest. 2010; Oncol 2(1):44\u201350.","DOI":"10.4251\/wjgo.v2.i1.44"},{"issue":"4","key":"508_CR19","first-page":"413","volume":"13","author":"E Galani","year":"2003","unstructured":"Galani E, Marx GM, Steer CB, Culora G, Harper PG. Pseudomyxoma peritonei: the 'controversial' disease. Int J Gynecol Cancer. 2003;13(4):413\u20138.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"508_CR20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/ejso.2001.1238","volume":"28","author":"PH Sugarbaker","year":"2002","unstructured":"Sugarbaker PH. The subpyloric space: an important surgical and radiologic feature in pseudomyxoma peritonei. Eur J Surg Oncol. 2002;28(4):443\u20136.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"508_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/1097-0142(20010701)92:1<85::AID-CNCR1295>3.0.CO;2-R","volume":"92","author":"BM Ronnett","year":"2001","unstructured":"Ronnett BM, Yan H, Kurman RJ, et al. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer. 2001;92(1):85\u201391.","journal-title":"Cancer."},{"issue":"12","key":"508_CR22","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1097\/00000478-199512000-00006","volume":"19","author":"BM Ronnett","year":"1995","unstructured":"Ronnett BM, Zahn CM, Kurman RJ, et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous arcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to \u201cpseudomyxoma peritonei\u201d. Am J Surg Pathol. 1995;19(12):1390\u2013408.","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"508_CR23","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.5858\/arpa.2011-0034-RA","volume":"135","author":"N Panarelli","year":"2011","unstructured":"Panarelli N, Yantiss R. Mucinous neoplasms of the appendix and peritoneum. Arch Pathol Lab Med. 2011;135(10):1261\u20138.","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"508_CR24","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1046\/j.1365-2168.2000.01553.x","volume":"87","author":"J Esquivel","year":"2000","unstructured":"Esquivel J, Sugarbaker PH. Clinical presentation of the Pseudomyxoma peritonei syndrome. Br J Surg. 2000;87(10):1414\u20138.","journal-title":"Br J Surg"},{"issue":"3","key":"508_CR25","first-page":"192","volume":"47","author":"Q Zhou","year":"2018","unstructured":"Zhou Q, Shi F, Zhao HY, Li Y, Song QK. Clinicopathologic characteristics of pseudomyxoma peritonei. Zhonghua Bing Li Xue Za Zhi. 2018;47(3):192\u20135.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"11","key":"508_CR26","first-page":"649","volume":"102","author":"AY Kshirsagar","year":"2004","unstructured":"Kshirsagar AY, Kulkarni SH, Wader JV, Satwik AA, Vinchurkar KM. Pseudomyxoma peritonei presenting as sub-acute large bowel obstruction. J Indian Med Assoc. 2004;102(11):649\u201350.","journal-title":"J Indian Med Assoc"},{"issue":"4","key":"508_CR27","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1245\/s10434-012-2790-8","volume":"20","author":"JC Leinwand","year":"2013","unstructured":"Leinwand JC, Bates GE, Allendorf JD, et al. Body surface area predicts plasma oxaliplatin and pharmacokinetic advantage in hyperthermic intraoperative intraperitoneal chemotherapy. Ann Surg Oncol. 2013;20(4):1101\u20134.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"508_CR28","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1177\/1066896917707041","volume":"25","author":"KV Shelekhova","year":"2017","unstructured":"Shelekhova KV, Zhuravlev AS, Krylova DD, et al. Pseudomyxoma Peritonei as a first manifestation of KRAS-mutated urachal mucinous cystadenocarcinoma of the bladder: a case report. Int J Surg Pathol. 2017;25(6):563\u20136.","journal-title":"Int J Surg Pathol"},{"issue":"9","key":"508_CR29","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1097\/00007611-200009000-00010","volume":"93","author":"A Nawaz","year":"2000","unstructured":"Nawaz A, Karakurum A, Weltman D, et al. Pseudomyxoma peritonei manifesting as intestinal obstruction. South Med J. 2000;93(9):891\u20133.","journal-title":"South Med J"},{"issue":"2","key":"508_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.11152\/mu.2013.2066.182.app","volume":"18","author":"RI Chira","year":"2016","unstructured":"Chira RI, Nistor-Ciurba CC, Mociran A, Mircea PA. Appendicular mucinous adenocarcinoma associated with pseudomyxoma peritonei, a rare and difficult imaging diagnosis. Med Ultrason. 2016;18(2):257\u20139.","journal-title":"Med Ultrason"},{"issue":"1","key":"508_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0016-5107(00)70395-6","volume":"51","author":"YT Lee","year":"2000","unstructured":"Lee YT, Lau JY, Chan KF, Chung SC, Sung JJ. Endosonographic features of pseudomyxoma peritonei. Gastrointest Endosc. 2000;51(1):85\u20138.","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"508_CR32","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1046\/j.1469-0705.2002.00611.x","volume":"19","author":"S Khan","year":"2002","unstructured":"Khan S, Patel AG, Jurkovic D. Incidental ultrasound diagnosis of pseudomyxoma peritonei in an asymptomatic woman. Ultrasound Obstet Gynecol. 2002;19(4):410\u20132.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"508_CR33","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.ejrad.2011.01.033","volume":"81","author":"J Krause","year":"2012","unstructured":"Krause J, Bergman A, Graf W, Nilsson A, Mahteme H. Ultrasonography findings and tumour quantification in patients with pseudomyxoma peritonei. Eur J Radiol. 2012;81(4):648\u201351.","journal-title":"Eur J Radiol"},{"issue":"9","key":"508_CR34","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.7863\/ultra.32.9.1565","volume":"32","author":"Y Li","year":"2013","unstructured":"Li Y, Guo A, Tang J, et al. Role of preoperative sonography in the diagnosis and pathologic staging of pseudomyxoma peritonei. J Ultrasound Med. 2013;32(9):1565\u201370.","journal-title":"J Ultrasound Med"},{"issue":"5","key":"508_CR35","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00261-012-9843-0","volume":"37","author":"Y Que","year":"2012","unstructured":"Que Y, Tao C, Wang X, Zhang Y, Chen B. Pseudomyxoma peritonei: some different sonographic findings. Abdom Imaging. 2012;37(5):843\u20138.","journal-title":"Abdom Imaging"},{"issue":"845","key":"508_CR36","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1259\/bjr.71.845.9691905","volume":"71","author":"CJ Tsai","year":"1998","unstructured":"Tsai CJ. Ultrasound features of disseminated adenomucinosis (pseudomyxoma). Br J Radiol. 1998;71(845):564\u20136.","journal-title":"Br J Radiol"},{"issue":"7","key":"508_CR37","doi-asserted-by":"publisher","first-page":"571","DOI":"10.14740\/jocmr2178w","volume":"7","author":"YN Chen","year":"2015","unstructured":"Chen YN, Lee JJ, Cheng SP, Tsai CH. Transformation of low-grade mucinous neoplasm of the appendix with pseudomyxoma peritonei to high-grade sarcomatoid carcinoma. J Clin Med Res. 2015;7(7):571\u20134.","journal-title":"J Clin Med Res"},{"issue":"5","key":"508_CR38","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/00365521.2017.1284896","volume":"52","author":"U Darr","year":"2017","unstructured":"Darr U, Renno A, Alkully T, et al. Diagnosis of Pseudomyxoma peritonei via endoscopic ultrasound guided fine needle aspiration: a case report and review of literature. Scand J Gastroenterol. 2017;52(5):609\u201312.","journal-title":"Scand J Gastroenterol"},{"issue":"12","key":"508_CR39","first-page":"1453","volume":"34","author":"M Takahashi","year":"1989","unstructured":"Takahashi M, Takekawa S, Suzuki K, Takahashi M, Ishiwata J. CT findings of pseudomyxoma peritonei. Rinsho Hoshasen. 1989;34(12):1453\u20137.","journal-title":"Rinsho Hoshasen"},{"issue":"10","key":"508_CR40","first-page":"798","volume":"89","author":"J Guilarte L\u00f3pez-Ma\u00f1as","year":"1997","unstructured":"Guilarte L\u00f3pez-Ma\u00f1as J, Cantero Hinojosa J, Mantas Avila JA. Computed tomography and sonographic features of pseudomyxoma peritonei. Rev EspEnferm Dig. 1997;89(10):798\u20139.","journal-title":"Rev EspEnferm Dig"},{"issue":"7","key":"508_CR41","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1053\/crad.2002.0942","volume":"57","author":"TV Sulkin","year":"2002","unstructured":"Sulkin TV, O'Neill H, Amin AI, Moran B. CT in pseudomyxoma peritonei: a review of 17 cases. Clin Radiol. 2002;57(7):608\u201313.","journal-title":"Clin Radiol"},{"issue":"3","key":"508_CR42","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1245\/s10434-017-6275-7","volume":"25","author":"M Bouquot","year":"2018","unstructured":"Bouquot M, Dohan A, Gayat E, et al. Prediction of Resectability in Pseudomyxoma Peritonei with a new CT score. Ann Surg Oncol. 2018;25(3):694\u2013701.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"508_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/BF01888499","volume":"17","author":"Y Matsuoka","year":"1992","unstructured":"Matsuoka Y, Ohtomo K, Itai Y, et al. Pseudomyxoma peritonei with progressive calcifications: CT findings. Gastrointest Radiol. 1992;17(1):16\u20138.","journal-title":"Gastrointest Radiol"},{"issue":"9","key":"508_CR44","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.diii.2014.02.009","volume":"95","author":"AD Diop","year":"2014","unstructured":"Diop AD, Fontarensky M, Montoriol PF, Da ID. CT imaging of peritoneal carcinomatosis and its mimics. Diagn Interv Imaging. 2014;95(9):861\u201372.","journal-title":"Diagn Interv Imaging"},{"issue":"3","key":"508_CR45","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s003300050692","volume":"9","author":"Y Matsuoka","year":"1999","unstructured":"Matsuoka Y, Masumoto T, Suzuki K, et al. Pseudomyxoma retroperitonei. J Eur Radiol. 1999;9(3):457\u20139.","journal-title":"J Eur Radiol"},{"issue":"4","key":"508_CR46","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ejso.2016.01.005","volume":"42","author":"B Menassel","year":"2016","unstructured":"Menassel B, Duclos A, Passot G, et al. Preoperative CT and MRI prediction of non-resectability in patients treated for pseudomyxoma peritonei from mucinous appendiceal neoplasms. Eur J Surg Oncol. 2016;42(4):558\u201366.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"508_CR47","first-page":"115","volume":"9","author":"JN Buy","year":"1989","unstructured":"Buy JN, Malbec L, Ghossain MA, Guinet C, Ecoiffier J. Magnetic resonance imaging of pseudomyxoma peritonei. Eur J Radiol. 1989;9(2):115\u20138.","journal-title":"Eur J Radiol"},{"issue":"9","key":"508_CR48","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1007\/s00259-016-3347-z","volume":"43","author":"J Dubreuil","year":"2016","unstructured":"Dubreuil J, Giammarile F, Rousset P, et al. FDG-PET\/ceCT is useful to predict recurrence of Pseudomyxoma peritonei. Eur J Nucl Med Mol Imaging. 2016;43(9):1630\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"508_CR49","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s13193-015-0486-9","volume":"7","author":"RA Seshadri","year":"2016","unstructured":"Seshadri RA, Hemanth RE. Diagnostic laparoscopy in the pre-operative assessment of patients undergoing Cytoreductive surgery and HIPEC for peritoneal surface malignancies. Indian J Surg Oncol. 2016;7(2):230\u20135.","journal-title":"Indian J Surg Oncol"},{"issue":"2","key":"508_CR50","first-page":"203","volume":"13","author":"Y Kotani","year":"2009","unstructured":"Kotani Y, Shiota M, Umemoto M, et al. Laparoscopic mucin removal in patients with pseudomyxoma peritonei. JSLS. 2009;13(2):203\u201336.","journal-title":"JSLS."},{"issue":"8","key":"508_CR51","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.ejso.2015.04.005","volume":"41","author":"S Kusamura","year":"2015","unstructured":"Kusamura S, Baratti D, Hutanu I, et al. The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Surg Oncol. 2015;41(8):1097\u2013105.","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"508_CR52","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/BF02574513","volume":"9","author":"S Ruth van","year":"2002","unstructured":"van Ruth S, Hart AA, Bonfrer JM, Verwaal VJ, Zoetmulder FA. Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2002;9(10):961\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"508_CR53","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00268-013-1988-7","volume":"37","author":"E Canbay","year":"2013","unstructured":"Canbay E, Ishibashi H, Sako S, et al. Preoperative carcinoembryonic antigen level predicts prognosis in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg. 2013;37(6):1271\u20136.","journal-title":"World J Surg"},{"issue":"5","key":"508_CR54","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ejso.2013.12.021","volume":"40","author":"P Taflampas","year":"2014","unstructured":"Taflampas P, Dayal S, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ. Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal Pseudomyxoma Peritonei: analysis of 519 patients. Eur J Surg Oncol. 2014;40(5):515\u201320.","journal-title":"Eur J Surg Oncol"},{"key":"508_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.humpath.2016.02.022","volume":"54","author":"P Nummela","year":"2016","unstructured":"Nummela P, Leinonen H, J\u00e4rvinen P, et al. Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei. Hum Pathol. 2016;54:47\u201354.","journal-title":"Hum Pathol"},{"issue":"2","key":"508_CR56","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/SLA.0b013e31818eec64","volume":"249","author":"D Baratti","year":"2009","unstructured":"Baratti D, Kusamura S, Nonaka D, Cabras AD, Laterza B, Deraco M. Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2009;249(2):243\u20139.","journal-title":"Ann Surg"},{"issue":"1","key":"508_CR57","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1525-1438.2007.00988.x","volume":"18","author":"CR Ferreira","year":"2008","unstructured":"Ferreira CR, Carvalho JP, Soares FA, Siqueira SA, Carvalho FM. Mucinous ovarian tumors associated with pseudomyxoma peritonei of adenomucinosis type: immunohistochemical evidence that they are secondary tumors. Int J Gynecol Cancer. 2008;18(1):59\u201365.","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"508_CR58","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1097\/01.MP.0000026617.52466.9F","volume":"15","author":"JT O'Connell","year":"2002","unstructured":"O'Connell JT, Hacker CM, Barsky SH. MUC2 is a molecular marker for pseudomyxoma peritonei. Mod Pathol. 2002;15(9):958\u201372.","journal-title":"Mod Pathol"},{"issue":"4","key":"508_CR59","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1365-2559.2006.02512.x","volume":"49","author":"D Nonaka","year":"2006","unstructured":"Nonaka D, Kusamura S, Baratti D, Casali P, Younan R, Deraco M. CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases. Histopathology. 2006;49(4):381\u20137.","journal-title":"Histopathology."},{"issue":"1","key":"508_CR60","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12967-016-0877-x","volume":"14","author":"F Pietrantonio","year":"2016","unstructured":"Pietrantonio F, Berenato R, Maggi C, et al. GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study. J Transl Med. 2016;14(1):125\u201331.","journal-title":"J Transl Med"},{"issue":"5","key":"508_CR61","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1177\/030089161209800508","volume":"98","author":"S Virz\u00ec","year":"2012","unstructured":"Virz\u00ec S, Iusco D, Bonomi S, Grassi A. Pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic chemotherapy: a 7-year single-center experience. Tumori. 2012;98(5):588\u201393.","journal-title":"Tumori."},{"issue":"1","key":"508_CR62","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1245\/s10434-012-2579-9","volume":"20","author":"N Tsilimparis","year":"2013","unstructured":"Tsilimparis N, Bockelmann C, Raue W, et al. Quality of life in patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is it worth the risk? Ann Surg Oncol. 2013;20(1):226\u201332.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"508_CR63","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/codi.12975","volume":"17","author":"B Moran","year":"2015","unstructured":"Moran B, Cecil T, Chandrakumaran K, et al. The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy. Color Dis. 2015;17(9):772\u20138.","journal-title":"Color Dis"},{"key":"508_CR64","doi-asserted-by":"crossref","unstructured":"Galan A, Rousset P, Mercier F, et al. Overall survival of pseudomyxoma peritonei and peritoneal mesothelioma patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy can be predicted by computed tomography quantified sarcopenia. Eur J Surg Oncol. 2018;44(11):1818\u201323.","DOI":"10.1016\/j.ejso.2018.07.060"},{"issue":"8","key":"508_CR65","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1245\/s10434-007-9462-0","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, Bijelic L, Sugarbaker PH. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms. Ann Surg Oncol. 2007;14(8):2289\u201399.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"508_CR66","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s002689900560","volume":"23","author":"A Gomez-Portilla","year":"1999","unstructured":"Gomez-Portilla A, Sugarbaker PH, Chang D. Second-look surgery after cytoreductive and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features. World J Surg. 1999;23(1):23\u20139.","journal-title":"World J Surg"},{"issue":"8","key":"508_CR67","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10434-999-0727-7","volume":"6","author":"PH Sugarbaker","year":"1999","unstructured":"Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol. 1999;6(8):727\u201331.","journal-title":"Ann Surg Oncol"},{"key":"508_CR68","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359\u201374.","journal-title":"Cancer Treat Res"},{"key":"508_CR69","doi-asserted-by":"publisher","unstructured":"Bjersand K, Mahteme H, Sundstr\u00f6m Poromaa I, et al. Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei. Ann Surg Oncol. 2015. \n                    https:\/\/doi.org\/10.1245\/s10434-015-4675-0\n                    \n                  .","DOI":"10.1245\/s10434-015-4675-0"},{"issue":"7","key":"508_CR70","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/jso.23547","volume":"109","author":"AU Blackham","year":"2014","unstructured":"Blackham AU, Swett K, Eng C, et al. Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2014;109(7):740\u20135.","journal-title":"J Surg Oncol"},{"issue":"2","key":"508_CR71","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00066-013-0470-7","volume":"190","author":"P Berkovic","year":"2014","unstructured":"Berkovic P, van de Voorde L, De Meerleer G, et al. Whole abdominopelvic radiotherapy in the palliative treatment of pseudomyxoma peritonei. Strahlenther Onkol. 2014;190(2):223\u20138.","journal-title":"Strahlenther Onkol"},{"key":"508_CR72","doi-asserted-by":"publisher","unstructured":"Kirby R, Liauw W, Zhao J, Morris D. Quality of life study following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei including redo procedures. Int J Surg Oncol. 2013. \n                    https:\/\/doi.org\/10.1155\/2013\/461041\n                    \n                  .","DOI":"10.1155\/2013\/461041"},{"issue":"20","key":"508_CR73","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30(20):2449\u201356.","journal-title":"J Clin Oncol"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-019-0508-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12893-019-0508-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-019-0508-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T23:13:52Z","timestamp":1587683632000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-019-0508-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,25]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["508"],"URL":"https:\/\/doi.org\/10.1186\/s12893-019-0508-6","relation":{},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,25]]},"assertion":[{"value":"4 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocols were approved by the Ethical Committee of the Second Affiliated Hospital of Dalian Medical University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for the publication of relevant medical information was obtained from the patient. A copy of the consent form is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"42"}}